Phase 2 Peritoneal Mesothelioma Clinical Trials
3 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–3 of 3 trials
Recruiting
Phase 2
IMMUNORARE5: A National Platform of 5 Academic Phase II Trials Coordinated by Lyon University Hospital to Assess the Safety and the Efficacy of the IMMUNOtherapy With Domvanalimab + Zimberelimab Combination in Patients With Advanced RARE Cancers
Peritoneal MesotheliomaAnaplastic Thyroid CarcinomasCarcinoid Tumor+3 more
Hospices Civils de Lyon154 enrolled15 locationsNCT06790706
Recruiting
Phase 2
A Study of Additional Chemotherapy After Surgery for People With Malignant Peritoneal Mesothelioma
Malignant MesotheliomaMesotheliomaMesothelioma, Malignant+2 more
Memorial Sloan Kettering Cancer Center64 enrolled13 locationsNCT06057935
Recruiting
Phase 2
Sintilimab, Bevacizumab, Pemetrexed, and Cisplatin for Unresectable MPeM
Malignant Peritoneal Mesothelioma, Advanced
Cancer Institute and Hospital, Chinese Academy of Medical Sciences28 enrolled1 locationNCT06543069